M&A Deal Summary

Werfen Acquires Immucor

On November 3, 2022, Werfen acquired medical products company Immucor from TPG for 2.0B USD

Acquisition Highlights
  • This is Werfen’s 1st transaction in the Medical Products sector.
  • This is Werfen’s largest (disclosed) transaction.
  • This is Werfen’s 1st transaction in the United States.
  • This is Werfen’s 1st transaction in Georgia.

M&A Deal Summary
Date 2022-11-03
Target Immucor
Sector Medical Products
Buyer(s) Werfen
Sellers(s) TPG
Deal Type Add-on Acquisition
Deal Value 2.0B USD

Target

Immucor

Norcross, Georgia, United States
Immucor, Inc. manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor is based in Norcross, Georgia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Werfen

Barcelona, Spain
Category Company
Founded 1996
Sector Medical Products
DESCRIPTION

Werfen is a developer, manufacturer and distributor of specialized diagnostic instruments, related reagents, automation workcells, and data management solutions for use primarily in hospitals and independent clinical laboratories. Werfen was founded in 1996 and is based in Barcelona, Spain.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Georgia) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1992
PE ASSETS 137.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.

DEAL STATS #
Overall 252 of 267
Sector (Medical Products) 11 of 11
Type (Add-on Acquisition) 89 of 94
State (Georgia) 7 of 7
Country (United States) 183 of 193
Year (2022) 9 of 11
Size (of disclosed) 28 of 71
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-28 iNova Pharmaceuticals

Singapore, Singapore

iNova Pharmaceuticals is a developer and marketer of over-the-counter and prescription medicines. iNova Pharmaceuticals was founded in 1958 and is based in Singapore.

Buy $1.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-09 Five Star Business Finance

Chennai, India

Five Star Business Finance is a non-bank finance company providing loans to nearly 40,000 customers. The company focuses on lending to the under-banked population, which typically lacks the financial records necessary to participate in the organized financial sector. Five Star Business Finance was founded in 1984 and is headquartered in Chennai, India.

Sell -
Mergr

Product

Company

Legal